Samsung BioLogics' Revised Valuation Based on P/B Multiple
In another regulatory filing, Samsung BioLogics presented a revised valuation based on P/B multiple. Obviously, there are still many people who are...
235 Views
Pass on the Deal, Put on the Watchlist
This Insight finalizes our view of the listing of Samsung BioLogics (SB) using information presented at the company’s roadshow meeting and included...
225 Views
3 Main Debatable Points to Be Discussed in Samsung BioLogics NDR This Week
Samsung BioLogics is quite busy with NDR this week. BioLogics executives are doing their best to justify the proposed valuation for BioLogics IPO....
252 Views
Smartkarma - ECM Coverage Weekly Update (10 Oct 2016)
Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.Accuracy Rate:Our accuracy...
214 Views
Samsung BioLogics IPO Part 3 - Valuation
Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...
329 Views